PLX

#3115
Protalix BioTherapeutics, Inc. Common Stock
2.8300 USD
+1.07%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
2.7890
2.8450
1年のレンジ
2.5850
3.1900
1日の変化
+1.07%
月次変化
-3.08%
6か月変化
-3.08%
1年の変化
-3.08%
以前の終値
2.8000
Open
2.8200
Bid
2.8300
Ask
2.8330
Low
2.7890
High
2.8450
ボリューム
288
Open full chart

Financials

Overview 明細書 Statistics
Quarterly Annual
Value 20202021202220232024 TTM
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios
Per share metrics

Protalix BioTherapeutics Inc (DE)

Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.

ニュース